Kaysen George A, Johansen Kirsten L, Cheng Su-Chun, Jin Chengshi, Chertow Glenn M
Division of Nephrology, Department of Medicine and Department of Biochemistry and Molecular Medicine, University of California at Davis, Davis, California, USA.
J Ren Nutr. 2008 Jul;18(4):323-31. doi: 10.1053/j.jrn.2008.04.002.
Serum albumin concentrations are associated with mortality, and respond to nutritional and inflammatory states. To explore whether changing demographics and practice patterns in dialysis have influenced serum albumin concentrations, we analyzed trends in serum albumin among incident patients on dialysis from 1995 through 2004.
Mean serum albumin concentrations declined significantly over time, even after accounting for changes in age, diabetes, body size, and other factors. Although laboratory assays were not uniform within or across years, serum albumin declined over time, regardless of the reported laboratory lower limit of normal. Moreover, serum albumin retained its potent association with mortality over time. Lower serum albumin was especially hazardous among younger patients and blacks, and was less hazardous among persons with diabetes as a primary cause of kidney disease.
Despite higher body weights and the initiation of dialysis earlier in the course of progressive chronic kidney disease, hypoalbuminemia remains common and hazardous to persons starting dialysis.
血清白蛋白浓度与死亡率相关,并对营养和炎症状态作出反应。为探讨透析人群结构和治疗模式的变化是否影响血清白蛋白浓度,我们分析了1995年至2004年新接受透析治疗患者的血清白蛋白变化趋势。
即使考虑到年龄、糖尿病、体型及其他因素的变化,血清白蛋白的平均浓度仍随时间显著下降。尽管各年份内及不同年份间实验室检测方法并不统一,但无论报告的实验室正常下限如何,血清白蛋白均随时间下降。此外,血清白蛋白与死亡率之间的密切关联随时间持续存在。血清白蛋白水平较低对年轻患者和黑人的危害尤其大,而对于以糖尿病作为肾病主要病因的患者危害较小。
尽管慢性进展性肾病患者体重增加且透析起始时间提前,但低白蛋白血症在开始透析的患者中仍然常见且具有危险性。